Scandinavian Real Heart
19.2
SEK
+4.92 %
HEART
First North Stockholm
Medical Equipment & Services
Health Care
1 following
+4.92%
+1.05%
-3.03%
-18.99%
-18.82%
-48.83%
-45.52%
-90.02%
-96.06%
-87.6%
realheart.se
Scandinavian Real Heart operates in medical technology. Today, the company's main focus is on research and development of heart pumps used among patients with severe heart conditions who are in the queue for transplant. The idea behind the heart pump is to use the product as a transitional solution before a final heart transplant is performed. The company is based in Västerås.
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
HEART
Daily low / high price
17 / 19.498
SEK
Market cap
39.71M SEK
Turnover
84.19K SEK
Volume
4.7K
Financial calendar
Annual report
2025-02-26
Major OwnersSource: Millistream Market Data AB
| Owner | Capital | Votes |
|---|---|---|
| European Innovation Council Accelerator | 18.9 % | 18.9 % |
| Eskilstunahem Förvaltnings AB | 8.1 % | 8.1 % |
| Avanza Pension | 4.8 % | 4.8 % |
| Azad Najar | 3.5 % | 3.5 % |
| Jonas Rudberg | 1.3 % | 1.3 % |
| Raux, Gilbert | 1.2 % | 1.2 % |
| Big Bear Holding AB | 0.9 % | 0.9 % |
| Nordnet Pensionsförsäkring | 0.8 % | 0.8 % |
| Abbe Dikmen | 0.8 % | 0.8 % |
| Bilend Najar | 0.6 % | 0.6 % |
ShowingAll content types
New Preclinical Simulation Data Shows Superior Effect of Realheart® TAH in Regulating Cardiovascular Function During Sleep
Realheart får patentgodkännande i Indien för sin enhet som används vid kirurgisk implantation av Realheart® TAH
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools